Evidence map›Paper›PMID 40425745›Full record

ArticleCommunications medicine2025

Risk factors for cardiogenic shock incidence and mortality after acute myocardial infarction: a systematic review and meta-analysis.

Mailikezhati Maimaitiming, Siwen Li, Kepei Huang, Mulatijiang Maimaitiming, Feng Liu, Sidney C Smith, Zhi-Jie Zheng, Yinzi Jin

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Sex disparities in revascularization strategies and mortality in infarct-related cardiogenic shock.Clinical research in cardiology : official journal of the German Cardiac Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mailikezhati MaimaitimingDepartment of Global Health, School of Public Health, Peking University, Beijing, China.ORCID http://orcid.org/0000-0002-6559-0211
Siwen LiDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Kepei HuangDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Mulatijiang MaimaitimingThe Second People's Hospital of Kashgar Prefecture, Kashgar, Xinjiang, China.
Feng LiuSuzhou Kowloon Hospital, School of Medicine Shanghai Jiaotong University, Suzhou, Jiangsu, China.
Sidney C SmithDivision of Cardiology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Zhi-Jie ZhengDepartment of Global Health, School of Public Health, Peking University, Beijing, China.
Yinzi JinDepartment of Global Health, School of Public Health, Peking University, Beijing, China. yzjin@bjmu.edu.cn.ORCID http://orcid.org/0000-0003-0634-3955

Funding

Beijing Nova Program 20230484284National Natural Science Foundation of China (National Science Foundation of China) 72274005Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) 9232009
6 · The paper itself

Abstract

backgroundCardiogenic shock (CS) is a serious complication of acute myocardial infarction (AMI), which could lead to severe health loss. This systematic review aimed to analyze the risk factors related to the incidence and poor outcomes of cardiogenic shock after acute myocardial infarction (AMI-CS), including in-hospital death, 30-day death and 1-year death.

methodsOriginal studies were systematically searched in PubMed and Embase up to November 2022. The summary odds ratio (OR) and 95% confidence interval (CI) of all studies were acquired based on a random effect model or fixed effect model. Subgroup analyses were conducted according to the study design, followed by sensitive analyses. The protocol was registered on PROSPERO (registration number: CRD42023466123).

resultsThere are 25 studies enrolled, including 12 cross-sectional studies, ten retrospective cohort studies, and three case-control studies. The pooled results reveal that female sex (OR, 1.10; 95% CI, 1.09-1.11), advanced age (OR, 1.06; 95% CI, 1.03-1.09), smoking (OR, 1.36; 95% CI, 1.26-1.45), diabetes (OR, 1.45; 95% CI, 1.08-1.82), and ST-segment elevation myocardial infarction (STEMI; OR, 1.99; 95% CI, 1.34-2.63) are significantly associated with the development of AMI-CS. Among these factors, all except smoking increase the risk of in-hospital death among AMI-CS patients. Advanced age (OR, 1.08; 95% CI, 1.04-1.12) and diabetes (OR, 1.77; 95% CI, 1.25-2.29) have negative impacts on 30-day death, while advanced age (OR, 2.10; 95% CI, 1.70-2.50) and STEMI (OR, 1.55; 95% CI, 1.15-1.95) are associated with 1-year death.

conclusionsOur findings highlight the significance of risk factors in predicting the incidence and prognosis of AMI-CS. Early identification and targeted interventions for individuals with these risk factors could potentially help prevent the occurrence of AMI-CS and improve patient outcomes.

Identifiers

PMID40425745
PMCPMC12117038

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.